RESUMEN
Endoscopic retrograde cholangiopancreatography (ERCP) is a common endoscopic procedure which plays a key role in the management of diseases of the bile ducts and the pancreas. Despite ERCP being performed routinely since more than 4 decades, it is still related to a considerable rate of complications with post-ERCP pancreatitis being the most frequent one. Lately, endoscopic techniques have evolved, and numerous modalities have been developed to prevent or manage ERCP-related complications, especially PEP, such as the use of intra-rectal non-steroidal anti-inflammatory drugs (NSAIDs), insertion of prophylactic stents in the pancreatic duct (PD) or intravenous hyperhydration. Knowledge of the various risk factors and applying validated preventive methods are keys in providing a safe procedure and optimizing overall patient care.
Asunto(s)
Colangiopancreatografia Retrógrada Endoscópica , Pancreatitis , Humanos , Antiinflamatorios no Esteroideos/uso terapéutico , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Pancreatitis/prevención & control , Pancreatitis/etiología , Factores de Riesgo , StentsRESUMEN
This article describes a case of Pseudomonas aeruginosa keratitis resulting from projection of biological fluids (bronchial secretions) on the face, mainly in the right eye. The employee presented with keratitis complicated by a corneal abscess. Consequently, the employee had a chronic and severe ocular surface and stoma destruction, possibly due to microbial proliferation into the surface tissues exacerbated by contact lenses. The infection was determined to be work related by experts. [Workplace Health Saf 2014;62(10):400-402.].